MacroGenics Inc.

NASDAQ: MGNX · Real-Time Price · USD
1.57
-0.05 (-3.09%)
At close: Aug 15, 2025, 3:59 PM
1.56
-0.64%
After-hours: Aug 15, 2025, 07:40 PM EDT

MacroGenics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
13.19M 17.73M 110.71M 10.8M 9.1M 10.72M 10.4M 13.14M 24.21M 71.18M 41.73M 26.01M 10.67M 13.62M 15.58M 30.37M 16.07M
Cost of Revenue
5.4M 5.49M 1.87M 2.82M 2.12M 2.06M 85K 1.18M 3.52M 1.79M 3.14M 2.4M 48K 947K 1.67M 22K 17K
Gross Profit
7.79M 12.24M 108.84M 7.97M 6.99M 8.66M 10.31M 11.96M 20.69M 69.39M 38.59M 23.61M 10.63M 12.68M 13.91M 30.35M 16.05M
Operating Income
-42.62M -52.84M 54.19M -58.18M -53.75M -49.35M -35.5M -44.96M -38.43M 11.98M -24.95M -41.81M -66.64M -58.24M -52.99M -40.28M -51.29M
Interest Income
1.68M 2.09M 2.12M 2.52M 2.69M 3.28M 3.06M 2.27M 1.07M 1.7M 142K 504K 195K n/a n/a n/a n/a
Pretax Income
-41.04M -14.48M 56.31M -55.66M -52.19M -46.07M 17.55M 57.47M -38.01M 12.8M -24.81M -41.3M -66.44M -58.02M -52.89M -39.94M -51.27M
Net Income
-41.04M -15.42M 56.31M -55.66M -52.19M -46.07M 17.55M 57.47M -38.25M 12.8M -24.67M -41.3M -66.25M -58.02M -52.89M -39.94M -51.27M
Selling & General & Admin
10.72M 27.81M 14.1M 14.42M 14.71M 12.56M 12.41M 13.69M 13.53M 13.67M 15.36M 13.67M 16.25M 15.58M 17.16M 15.23M 15.04M
Research & Development
39.7M 38.89M 40.54M 51.73M 46.03M 45.45M 30.13M 43.23M 45.87M 45.65M 48.19M 51.74M 61.44M 55.85M 49.82M 55.78M 53.12M
Other Expenses
n/a -1.62M n/a n/a n/a n/a 3.27M n/a -283K -1.92M 142K 504K -428K n/a 101K n/a 21K
Operating Expenses
50.42M 65.08M 54.65M 66.16M 60.74M 58.01M 45.81M 56.92M 59.12M 57.4M 63.55M 65.41M 77.26M 70.91M 66.9M 70.63M 67.35M
Interest Expense
91K n/a n/a 6K 1.13M n/a n/a 774K 656K n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
55.82M 70.57M 56.52M 68.98M 62.85M 60.07M 45.9M 58.1M 62.64M 59.19M 66.69M 67.81M 77.31M 71.86M 68.56M 70.65M 67.36M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a 239K n/a -142K n/a -195K n/a n/a n/a n/a
Shares Outstanding (Basic)
62.97M 62.62M 62.74M 62.66M 62.29M 62.07M 61.98M 61.88M 61.81M 61.43M 61.46M 61.38M 61.32M 61.17M 61.17M 60.07M 56.97M
Shares Outstanding (Diluted)
62.97M 62.62M 62.87M 62.66M 62.29M 62.07M 62.24M 62.26M 61.81M 61.43M 61.46M 61.38M 61.32M 61.17M 61.17M 60.07M 57.2M
EPS (Basic)
-0.65 -0.25 0.90 -0.89 -0.84 -0.74 0.28 0.93 -0.62 0.21 -0.4 -0.67 -1.08 -0.95 -0.86 -0.66 -0.9
EPS (Diluted)
-0.65 -0.25 0.90 -0.89 -0.84 -0.74 0.28 0.92 -0.62 0.21 -0.4 -0.67 -1.08 -0.95 -0.86 -0.66 -0.9
EBITDA
-39.17M -12.45M 58.14M -53.85M -49.22M -44.17M 19.5M 61.05M -34.37M 15.21M -21.97M -38.43M -63.53M -55.07M -50.09M -37.15M -48.54M
EBIT
-40.95M -14.5M 56.31M -55.66M -51.06M -46.07M 17.55M 58.24M -37.35M 11.98M -24.81M -41.3M -66.44M -58.24M -52.99M -40.28M -51.29M
Depreciation & Amortization
1.77M 2.05M 1.83M 1.81M 1.84M 1.9M 1.95M 2.81M 2.98M 3.23M 2.84M 2.88M 2.91M 2.95M 2.8M 2.78M 2.73M